You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cannabinoid receptor

Showing 1 - 25 of 7,282
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alcoholism Trial in West Haven (THC, Placebo)

Completed
  • Alcoholism
  • West Haven, Connecticut
    VA Connecticut Healthcare System
Feb 23, 2022

Diabete Type 2, Abdominal Obesity Trial in Dijon (Sampling of adipose tissue)

Recruiting
  • Diabete Type 2
  • Abdominal Obesity
  • Sampling of adipose tissue
  • Dijon, France
    Chu Dijon Bourgogne
Oct 5, 2021

Amyotrophic Lateral Sclerosis Trial in St. Gallen ([18F]-RoSMA-18-d6)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • St. Gallen, Switzerland
    Muskelzentrum/ALS-Clinic, Kantonsspital St. Gallen
May 19, 2023

Sleep Disorder, Healthy Trial in Baltimore (Sleep Fragmentation, Within-Subject test of blinded study medication (stimulant,

Recruiting
  • Sleep Disorder
  • Healthy
  • Sleep Fragmentation
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins School of Medicine
Nov 14, 2022

Esophageal Diseases Trial in Philadelphia (Dronabinol, Placebo)

Withdrawn
  • Esophageal Diseases
  • Philadelphia, Pennsylvania
    Temple University Hospital
Sep 25, 2019

Bipolar Affective Disorder, Currently in Remission, Bipolar Disorder I, Bipolar Disorder II Trial in Detroit (Wim Hof method)

Unknown status
  • Bipolar Affective Disorder, Currently in Remission
  • +2 more
  • Wim Hof method
  • Detroit, Michigan
    Children's Hospital of Michigan
Nov 18, 2019

Healthy Volunteers Trial in Baltimore (Nabllone, CP-945,598, Hypoglycemic Clamp)

Completed
  • Healthy Volunteers
  • Nabilone
  • +3 more
  • Baltimore, Maryland
    National Institute of Aging, Clinical Research Unit
Jan 18, 2023

Suppression of Upper Lip Hair Growth Using Novel Hemp Extract

Not yet recruiting
  • Hirsutism
  • Hair Diseases
  • Narcissus Tazetta Bulb Extract and Novel Hemp Extract
  • (no location specified)
Aug 15, 2023

Fatigue, Stress, Job Trial in Poznan (Lactobacillus helveticus Rosell-52 and Bifidobacterium longum Rosell-175 (Sanprobi

Recruiting
  • Fatigue
  • Stress, Job
  • Lactobacillus helveticus Rosell-52 and Bifidobacterium longum Rosell-175 (Sanprobi Stress)
  • Starch (placebo)
  • Poznań, Poland
    Poznan University of Physical Education
Oct 4, 2022

Prostaglandin and Cannabinoid Receptors in EoE

Recruiting
  • Eosinophilic Esophagitis (EoE)
  • Biopsy samples
  • Blood samples
  • Graz, Austria
    Medical University of Graz
Aug 31, 2021

Cannabis, Ketamine Trial in West Haven (Active Delta-9-THC, Placebo Delta-9-THC, Active Ketamine)

Recruiting
  • Cannabis
  • Ketamine
  • Active Delta-9-THC
  • +3 more
  • West Haven, Connecticut
    VA Connecticut Healthcare System
Jan 27, 2022

Observational Study About Patients Diagnosed With NAFLD

Recruiting
  • Nonalcoholic Fatty Liver Disease
    • Changsha, Hunan, China
      Department of Infectious Disease, Xiangya Hospital, Central Sout
    Nov 25, 2022

    Imaging Cannabinoid Receptors Using Positron Emission Tomography

    Recruiting
    • Schizophrenia
    • +6 more
    • [11-C]OMAR
    • New Haven, Connecticut
      Connecticut Mental Health Center, Clinical Neuroscience Research
    Feb 23, 2022

    Trichotillomania, Skin-Picking Trial in Chicago (Dronabinol, Placebo)

    Completed
    Has Results
    • Trichotillomania
    • Skin-Picking
    • Chicago, Illinois
      University of Chicago
    May 11, 2022

    Schizophrenia, Schizoaffective Disorder, Healthy Trial in New Haven (11C-EMO - A Novel PET Radiotracer for Muscarinic M1

    Recruiting
    • Schizophrenia
    • +2 more
    • 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
    • New Haven, Connecticut
      Connecticut Mental Health Center
    Sep 16, 2022

    Cannabis Use Disorder Trial in New Haven ([18F]FPEB with PET, Cannabis abstinence)

    Not yet recruiting
    • Cannabis Use Disorder
    • [18F]FPEB with PET
    • Cannabis abstinence
    • New Haven, Connecticut
      The Anlyan Center
    Dec 22, 2022

    OMAR Opioid Use Disorder

    Not yet recruiting
    • Healthy Control
    • Opioid Use Disorder
    • (no location specified)
    Jan 3, 2023

    Schizophrenia, Schizoaffective Disorder, Obesity Trial in Baltimore, Catonsville (Rimonabant, Placebo)

    Terminated
    Has Results
    • Schizophrenia
    • +4 more
    • Baltimore, Maryland
    • +3 more
    Oct 31, 2019

    Irritable Bowel Syndrome Trial in Roma (palmithoylethanolamide/polydatin, )

    Recruiting
    • Irritable Bowel Syndrome
    • palmithoylethanolamide/polydatin
    • placebo
    • Roma, Rome, Italy
      Prof Giovanni Di Nardo
    May 10, 2023

    Obesity Trial in Turku (fMRI imaging, [11C]carfentanil PET scan, [18F]FMPEP-d2 PET scan)

    Active, not recruiting
    • Obesity
    • fMRI imaging
    • +7 more
    • Turku, Finland
      Turku PET Centre (Turku University Hospital)
    Dec 16, 2021

    Cannabis Withdrawal Trial (PP-01 High Dose, PP-01 Low Dose, Placebo)

    Not yet recruiting
    • Cannabis Withdrawal
    • PP-01 High Dose
    • +4 more
    • (no location specified)
    Aug 9, 2022

    ASSIST: A Surveillance Study of Illicit Substance Toxicity

    Not yet recruiting
    • Overdose, Drug
    • +7 more
    • Surplus sample toxicology analysis
    • Glasgow, United Kingdom
      Queen Elizabeth University Hospital, NHS GGC
    Apr 8, 2022

    Cannabis, Psychotic Disorders Trial in West Haven (THC, Placebo)

    Active, not recruiting
    • Cannabis
    • Psychotic Disorders
    • West Haven, Connecticut
      VA Connecticut Healthcare System
    Jul 28, 2022

    Kidney Diseases, Diabetic Nephropathies, Diabetes Complications Trial in San Antonio (GFB-024, Placebo)

    Completed
    • Kidney Diseases
    • +4 more
    • San Antonio, Texas
      Worldwide Clinical Trials
    Mar 24, 2022

    Fear Conditioning Trial in West Haven (PF-04457845, Placebo)

    Completed
    • Fear Conditioning
    • West Haven, Connecticut
      VA Connecticut Healthcare System
    Feb 24, 2022